AI for Biologic and Large Molecule Engineering

Oct 29, 2026
Discovery Chemistry

Understand how predictive and generative models are enabling antibody, peptide and protein sequence design and optimization.

Analyze how structure-aware AI is improving affinity, stability, specificity and immunogenicity profiles across biologic modalities.

Determine how AI is accelerating biologic discovery while expanding the accessible design space for large molecules.

Speakers
Saber Meamardoost
Saber Meamardoost, Associate Director AI/ML and Data Science - Boehringer Ingelheimm